Vimarsana
Biggest News Aggregation in the World

Page 10 - Scientific Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scientific Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scientific Session Today - Breaking & Trending Today

Evermed, ACC launch ACC Anywhere, the "Netflix of Cardiology" - Vimarsana News

Evermed, ACC launch ACC Anywhere, the "Netflix of Cardiology"

/PRNewswire/ -- Evermed and the American College of Cardiology (ACC) have announced the launch of ACC Anywhere, a new content hub that provides cardiologists...

Non-Statin Therapies for Patients at High Risk for Cardiovascular Disease - Vimarsana News

Non-Statin Therapies for Patients at High Risk for Cardiovascular Disease

Erin Michos, MD, MHS, opens a discussion surrounding the utilization of bempedoic acid for patients with intolerance to statin-based therapies.

Source: ajmc.com
BioSig Technologies : Annual report pursuant to Section 13 and 15(d) - Vimarsana News

BioSig Technologies : Annual report pursuant to Section 13 and 15(d)

Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases , which amended... | March 31, 2023

Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results - Vimarsana News

Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results

LONDON and SALT LAKE CITY, March 30, 2023 -- Renalytix plc , an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive... | March 30, 2023

Evermed, ACC Launch ACC Anywhere, the 'Netflix of Cardiology' - Vimarsana News

Evermed, ACC Launch ACC Anywhere, the 'Netflix of Cardiology'

The hub contains original content from five conferences including ACC’s 2022 and 2023 Annual Scientific Session, with additional conferences to be added in the future